301246 宏源藥業
按盤價 
29.970 +4.080 (+15.759%)
29.970 +4.080 (+15.759%) | 2026/03 - 三個月 | 2025/12 | 2024/12 | 2023/12 | 2022/12 | 盈利能力分析 |
| 淨資產收益率 ROE (%) | 3.184 | 2.700 | 1.180 | 2.693 | 22.933 |
| 總資產報酬率 ROA (%) | 2.319 | 1.986 | 0.897 | 1.830 | 13.786 |
| 投入資產回報率 ROIC (%) | 2.605 | 2.263 | 1.012 | 2.144 | 17.436 | 邊際利潤分析 |
| 銷售毛利率 (%) | 32.002 | 18.776 | 12.185 | 12.987 | 23.324 |
| 營業利潤率 (%) | 26.101 | 8.160 | 3.391 | 5.141 | 23.256 |
| 息稅前利潤/營業總收入 (%) | 23.938 | 8.041 | 3.203 | 4.631 | 22.630 |
| 淨利潤/營業總收入 (%) | 20.496 | 6.065 | 2.906 | 4.242 | 21.069 | 收益指標分析 |
| 經營活動淨收益/利潤總額(%) | 96.842 | 99.201 | 97.242 | 90.912 | 66.078 |
| 價值變動淨收益/利潤總額(%) | 15.002 | 22.588 | 11.510 | 22.606 | 35.567 |
| 營業外收支淨額/利潤總額(%) | -11.380 | -8.614 | -0.593 | -7.190 | -0.410 | 償債能力分析 |
| 流動比率 (X) | 2.884 | 2.656 | 2.682 | 3.500 | 1.261 |
| 速動比率 (X) | 2.595 | 2.399 | 2.444 | 3.291 | 0.994 |
| 資產負債率 (%) | 26.670 | 27.671 | 25.130 | 22.845 | 45.453 |
| 帶息債務/全部投入資本 (%) | 17.136 | 15.754 | 12.843 | 11.754 | 28.092 |
| 股東權益/帶息債務 (%) | 474.014 | 523.450 | 663.789 | 733.974 | 244.423 |
| 股東權益/負債合計 (%) | 275.000 | 261.437 | 297.906 | 337.728 | 120.007 |
| 利息保障倍數 (X) | 47.514 | 15.231 | -19.111 | -28.042 | -42.601 | 營運能力分析 |
| 應收賬款周轉天數 (天) | 66.731 | 63.663 | 45.439 | 45.928 | 39.143 |
| 存貨周轉天數 (天) | 61.511 | 67.362 | 53.485 | 54.810 | 83.884 |
| 備註： | 報價延遲最少15分鐘，資料更新時間為 30/04/2026 16:30 |
- 經濟通
- 強化版MQ
- 強化版TQ
- 財曆
- Mobile
Web
